Hajime Baba

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Apathy Assessment in Neurocognitive Disorders: Revisiting a Supportive Clinical Feature for the Early Recognition of Prodromal Dementia With Lewy Bodies.

Apathy Assessment in Neurocognitive Disorders: Revisiting a Supportive Clinical Feature for the Early Recognition of Prodromal Dementia With Lewy Bodies.

Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society

Published: May 15, 2026

Pharmacological treatment of schizophrenia: Japanese Expert Consensus 2025.

Pharmacological treatment of schizophrenia: Japanese Expert Consensus 2025.

Journal: Schizophrenia (Heidelberg, Germany)

Published: April 03, 2026

Serum Amyloid β Oligomer May Predict Treatment Response in Middle-Aged and Late-Life Patients With Depression.

Serum Amyloid β Oligomer May Predict Treatment Response in Middle-Aged and Late-Life Patients With Depression.

Journal: Neuropsychopharmacology reports

Published: February 01, 2026

Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta-Analysis.

Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta-Analysis.

Journal: Neuropsychopharmacology reports

Published: December 12, 2024

Cognitive impairment of medicated patients with remitted depression and low anticholinergic activity.

Cognitive impairment of medicated patients with remitted depression and low anticholinergic activity.

Journal: Journal of affective disorders

Published: March 21, 2024

Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta-analysis.

Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta-analysis.

Journal: Neuropsychopharmacology reports

Published: December 13, 2023

Neuroaxonal damage as a mechanism underlying late-life depression.

Neuroaxonal damage as a mechanism underlying late-life depression.

Journal: Psychiatry and clinical neurosciences

Published: November 29, 2023

Treatment strategy for late-life depression.

Treatment strategy for late-life depression.

Journal: PCN reports : psychiatry and clinical neurosciences

Published: March 31, 2023

Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study.

Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study.

Journal: European journal of clinical pharmacology

Published: February 15, 2023

Serum levels of brain-derived neurotrophic factor in remission, but not the acute phase, may predict the development from depression to dementia.

Serum levels of brain-derived neurotrophic factor in remission, but not the acute phase, may predict the development from depression to dementia.

Journal: International journal of geriatric psychiatry

Published: January 26, 2023

Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission.

Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission.

Journal: Neuropsychopharmacology reports

Published: May 01, 2022

Clinical course and serum amyloid β levels in elderly patients with major depressive disorder.

Clinical course and serum amyloid β levels in elderly patients with major depressive disorder.

Journal: Journal of affective disorders

Published: March 31, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026